Dengue: Anvisa creates group to evaluate the safety of the Butantan vaccine
⚡ Quick Summary
Adverse events, benefits and risks of the immunizer will be analyzed
🗞️ 1 sources covered this story
📰 Related Articles
Cold inside the house? See how to choose the best portable heater
CartaCapital
What is the best ally for quick recipes?
CartaCapital
EMEL. Is it possible to (successfully) contest traffic fines?
Observador
Alopecia areata: when the immune system attacks the hair
Observador